Article and Video CATEGORIES

Cancer Journey

Search By

 Dr. Matthew Kurian completed a 6-year accelerated BS/MD program through Northeast Ohio Medical University and completed his internal medicine residency training at the University of Cincinnati Medical Center. He joined St. Elizabeth’s Cancer Center in Edgewood, Kentucky as a lung and breast cancer specialist. He has a passion for bringing academic level care into the community through the enrollment of patients in clinical trials and improving access, equity, and education for patients and medical trainees.

Program: Patient Education Ambassadors 2023-24
The 2023-2024 GRACE Patient Education Ambassadors discuss topics in a variety of cancers, from screening and treating prostate cancer to aiding in the cost of cancer treatment.
Author
Matthew Kurian, MD - Guest Faculty
Image
Patient Education Ambassadors 2023-24

Drs. Matthew Kurian, Karan Jatwani, and Karine Tawagi discuss risk factors for developing prostate cancer, PSA test in prostate cancer screening, biopsies in prostate cancer, among other relevant information about prostate cancer.

To watch the full playlist click here.

 

Video Language

Next Previous link

Previous PostNext Post

Related Content

Article
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
Image
2025 Spanish Targeted Therapy in Lung Cancer Patient Forum
Article
Da click aquí para más información y para registrarte ahora